Research
Mixed
Commercial direct-to-consumer (DTC) genetic tests for personalized nutrition often lack scientific backing, provide insufficient result descriptions, and draw inferences that are not supported by robust evidence, particularly when based on single gene variants.
Be skeptical of DTC genetic nutrition tests. They are largely unregulated and often base advice on single genes, ignoring the complex polygenic nature of health. The paper states these tests often lack scientific backing. Use them for curiosity, not as a substitute for evidence-based dietary guidelines.
StrongRefutesHIGH confidence
Genetic testing is mainly an unregulated market in the sense that they provide insufficient descriptions of results and draw inferences which lack of scientific backing (43-48).
Why this rating
The paper explicitly cites multiple references (43-48) and frameworks (Grimaldi et al) criticizing the current state of the market.
Source
Genetic test for the prescription of diets in support of physical activity.
Zakira Naureen et al. · PubMed · 2020
DOI 10.23750/abm.v91i13-s.10584
narrative_reviewCited 8×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →